Cepheid, Bruker, and Response Genetics Wrap up UBS Conference | GenomeWeb

NEW YORK (GenomeWeb News) – The UBS Global Life Sciences Conference wrapped up today with a handful of 'omics-related life science firms presenting to investors. Below are summaries of their pitches.

Cepheid

CFO Andrew Miller reiterated previous company statements that the firm has 14 tests currently in development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.